Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.

by Lin L Liu, Fei Li, William Pao, Franziska Michor
Published 2015-01-01

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.

by Jasmine Foo, Lin L Liu, Kevin Leder, Markus Riester, Yoh Iwasa, Christoph Lengauer, Franziska Michor
Published 2015-09-01

Probabilistic Modeling of Reprogramming to Induced Pluripotent Stem Cells

by Lin L. Liu, Justin Brumbaugh, Ori Bar-Nur, Zachary Smith, Matthias Stadtfeld, Alexander Meissner, Konrad Hochedlinger, Franziska Michor
Published 2016-12-01

Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies.

by Kimiyo N Yamamoto, Akira Nakamura, Lin L Liu, Shayna Stein, Angela C Tramontano, Uri Kartoun, Tetsunosuke Shimizu, Yoshihiro Inoue, Mitsuhiro Asakuma, Hiroshi Haeno, Chung Yin Kong, Kazuhisa Uchiyama, Mithat Gonen, Chin Hur, Franziska Michor
Published 2019-01-01